Over the past 27 years, Molecular Medicine Tri-Conference has served as the leading international meeting place for the precision medicine community. As we face the unprecedented task of fighting this pandemic and working together while maintaining social distancing, Cambridge Healthech Institute once again takes the leadership role of bringing together the life science community at the Tri-Con Virtual 2021. Join international thought leaders to discuss the latest research and technologies in COVID-19 diagnostics, vaccines and biotherapeutics, point-of-care diagnostics, biomarkers and liquid biopsy, data analytics and artificial intelligence. In addition to the leading research and technology presentations you have come to expect at the Tri-Con, now available for on-demand viewing, we have added interactive panel discussions and structured networking opportunities, for a comprehensive 3-day program designed to maximize collaboration and innovation… all without leaving your computer.
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.
The CRISPR Journal is the only peer-reviewed publication dedicated to the science and applications of gene editing. Spearheaded by Editor-in-Chief Rodolphe Barrangou, PhD and aided by a diverse and accomplished editorial board, the Journal provides a high-profile forum for cutting-edge international original research papers, as well as a compelling mixture of frontmatter content— review articles, perspectives, profiles, and commentary spanning not only matters of research but the many social, ethical, and business issues confronting the field. The CRISPR Journal centralizes essential information and analysis on this revolutionary technology in a single location with the aim of solidifying and growing the community of innovative researchers, practitioners, policymakers, and activists who make up the field of gene editing.
Genetic Testing and Molecular Biomarkers is the leading peer-reviewed journal covering all aspects of human genetic testing including molecular biomarkers. The Journal provides a forum for the development of new technology; the application of testing to decision making in an increasingly varied set of clinical situations; ethical, legal, social, and economic aspects of genetic testing; and issues concerning effective genetic counseling. This is the definitive resource for researchers, clinicians, and scientists who develop, perform, and interpret genetic tests and their results.
View this virtual event at Molecular Medicine Tri-Conference